EP News Bureau

Abend brings 25 years of global business leadership experience, with a track record of driving customer-centric strategies and…

Biologic approvals, drug delivery advancements, GLP-1 generics and the long-sought funding return to drive a record year in 2025,…

Brexpiprazole is an atypical antipsychotic used as an adjunctive therapy to antidepressants for the treatment of major depressive…

The objective of this conclave was to ideate, explore and collaborate on the learnings of the pandemic, and to build a more robust…

Over 8,000 visitors expected at Vitafoods India 2025, highlighting the event's growing role as a key networking hub

LEQEMBI’s subcutaneous formulation could simplify maintenance therapy for Alzheimer’s patients, offering a 15-second at-home…

Industry leaders share their expectations from the upcoming Union budget 2025-26. Increased allocation for R&D and…

Industry experts highlight the evolving dynamics, regulatory needs, and personalised solutions driving the nutra market ahead of…

While mega-cap companies dominate the GLP-1R market and are expected to maintain their stronghold in 2030, three smaller biotechs…

TX-478 could potentially address 30-40 per cent of people with hormone-positive breast cancer, building on Lilly's advancements…